SRGAP2 and cancer: Immunochemistry of ductal carcinoma of breast showed that srGAP2 aggregation was more pronounced in “budding” cancer cells, which was invading into the surrounding basement membrane; srGAP2 expression was significantly increased in the invasive ductal carcinoma (Figure 1A).